3D-Printed Cervical Cage Receives FDA Clearance

Originally titled '3D-Printed Cervical Cage Receives FDA Clearance'

Stryker’s Tritanium C anterior cervical cage features a porous structure to promote tissue growth.


Facebook Share Icon LinkedIn Share Icon Twitter Share Icon Share by EMail icon Print Icon

Stryker’s Spinal Division has announced that its Tritanium C anterior cervical cage, a 3D-printed interbody fusion cage intended for use in the cervical spine, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Constructed using Tritanium In-Growth technology, the product has uses a highly porous titanium material designed for bone in-growth and biological fixation. The material may be able to wick or retain fluid, in contrast to traditional titanium material. The design creates a favorable environment for cell attachment and proliferation, the company says.

The cervical cage features an open central graft window and lateral windows to help reduce stiffness of the cage and minimize subsidence, while size of the window encourages bone graft containment. The cage has serrations on the superior and inferior surfaces designed for bidirectional fixation and maximizing the surface area for endplate contact with the cage. Its smooth posterior edges facilitate insertion and protect soft tissue and anatomy. The cage’s design is adaptable to a variety of patient anatomies.